Boston Business JournalCambridge gene therapy firm Dimension Therapeutics to be acquiredBoston Business Journal… of our partners in the research and clinical communities, who together have made significant contributions to the progress of AAV technol… Continue reading
Phys.OrgStem cell treatment for children with spina bifida helps dogs firstPhys.OrgAn English bulldog undergoes surgery for spina bifida at the UC Davis Veterinary Medical Teaching Hospital. The dog is part of a pair of puppies being treated for spina … Continue reading
|
Sangamo And Pfizer Announce First Patient Receives Treatment In Phase 1/2 Clinical Trial Evaluating SB-525 …
Markets Insider 25, 2017 /PRNewswire/ — Sangamo Therapeutics, Inc. (Nasdaq: SGMO) and Pfizer Inc. (NYSE: PFE) today announced that the first patient received treatment in the Phase 1/2 clinical trial (“the Alta trial”) evaluating SB-525, an investigational gene … |
Endpoints News |
Regenxbio bags one of its gene therapy vector partners, buying out a struggling Dimension
Endpoints News Gene therapy player Regenxbio $RGNX has struck a deal to buy the struggling Dimension Therapeutics $DMTX after a setback in the clinic earlier this year brutally hammered the biotech’s market cap down to only $30 million. Regenxbio has agreed to buy … REGENXBIO to Acquire Dimension TherapeuticsNasdaq |
East Anglian Daily Times |
Ed Sheeran’s backing sees thousands join stem cell register to help find seven-year-old Bury St Edmunds girl a donor
East Anglian Daily Times Undated handout photo of Luke Concannon encouraging people to sign up to register as stem cell donors. Seven-year-old Jasmi Lindberg Cooke, who has been battling acute lymphoblastic leukaemia for three years, is desperately searching for a matching … |